Boster DR - Search Results

1

Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study.

Klein EJ, Boster DR, Stapp JR, Wells JG, Qin X, Clausen CR, Swerdlow DL, Braden CR, Tarr PI. Klein EJ, et al. Among authors: boster dr. Clin Infect Dis. 2006 Oct 1;43(7):807-13. doi: 10.1086/507335. Epub 2006 Aug 22. Clin Infect Dis. 2006. PMID: 16941358

2

Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study.

Klein EJ, Stapp JR, Clausen CR, Boster DR, Wells JG, Qin X, Swerdlow DL, Tarr PI. Klein EJ, et al. Among authors: boster dr. J Pediatr. 2002 Aug;141(2):172-7. doi: 10.1067/mpd.2002.125908. J Pediatr. 2002. PMID: 12183710

3

Etiology of diarrhea in pediatric outpatient settings.

Denno DM, Stapp JR, Boster DR, Qin X, Clausen CR, Del Beccaro KH, Swerdlow DL, Braden CR, Tarr PI. Denno DM, et al. Among authors: boster dr. Pediatr Infect Dis J. 2005 Feb;24(2):142-8. doi: 10.1097/01.inf.0000151031.47761.6d. Pediatr Infect Dis J. 2005. PMID: 15702043

4

ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.

Jelacic S, Wobbe CL, Boster DR, Ciol MA, Watkins SL, Tarr PI, Stapleton AE. Jelacic S, et al. Among authors: boster dr. J Infect Dis. 2002 Jan 15;185(2):214-9. doi: 10.1086/338480. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807695

5

Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children.

Qin X, Razia Y, Johnson JR, Stapp JR, Boster DR, Tsosie T, Smith DL, Braden CR, Gay K, Angulo FJ, Tarr PI. Qin X, et al. Among authors: boster dr. Antimicrob Agents Chemother. 2006 Oct;50(10):3325-9. doi: 10.1128/AAC.00548-06. Antimicrob Agents Chemother. 2006. PMID: 17005812 Free PMC article.

6

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI. Wong CS, et al. Among authors: boster dr. Clin Infect Dis. 2012 Jul;55(1):33-41. doi: 10.1093/cid/cis299. Epub 2012 Mar 19. Clin Infect Dis. 2012. PMID: 22431799 Free PMC article.

7

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.

Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI. Chandler WL, et al. Among authors: boster dr. N Engl J Med. 2002 Jan 3;346(1):23-32. doi: 10.1056/NEJMoa011033. N Engl J Med. 2002. PMID: 11777999 Free article.

8

Platelet-activating factor and Escherichia coliO157:H7 infections.

Smith JM, Jones F, Ciol MA, Jelacic S, Boster DR, Watkins SL, Williams GD, Tarr PI, Henderson WR Jr. Smith JM, et al. Among authors: boster dr. Pediatr Nephrol. 2002 Dec;17(12):1047-52. doi: 10.1007/s00467-002-0970-7. Epub 2002 Nov 5. Pediatr Nephrol. 2002. PMID: 12478356

9

Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin.

Johnson JR, Jerome C, Boster DR, Stapleton AE, Tarr PI. Johnson JR, et al. Among authors: boster dr. J Clin Microbiol. 2002 Jun;40(6):2247-8. doi: 10.1128/JCM.40.6.2247-2248.2002. J Clin Microbiol. 2002. PMID: 12037099 Free PMC article.

10

Preclinical safety of recombinant human thrombin.

Heffernan JK, Ponce RA, Zuckerman LA, Volpone JP, Visich J, Giste EE, Jenkins N, Boster D, Pederson S, Knitter G, Palmer T, Wills M, Early RJ, Rogge MC. Heffernan JK, et al. Regul Toxicol Pharmacol. 2007 Feb;47(1):48-58. doi: 10.1016/j.yrtph.2006.07.006. Epub 2006 Sep 12. Regul Toxicol Pharmacol. 2007. PMID: 16971028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page